Tag: Efferon
-
Efferon secures €2.5M to grow blood purification platform
Biotech company Efferon has raised €2.5 million in a seed funding round led by private investors from the DACH region to support the European commercial expansion of Efferon LPS, its hemoadsorption device approved for the treatment of sepsis and septic shock. Efferon develops multimodal hemoadsorption therapeutic devices designed to remove endotoxins and inflammatory mediators directly read more
Written by
